{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:36:58Z","timestamp":1778254618216,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s10875-023-01580-x","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T03:02:38Z","timestamp":1694401358000},"page":"2011-2021","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A Novel Homozygous Mutation Causing Complete TYK2 Deficiency, with Severe Respiratory Viral Infections, EBV-Driven Lymphoma, and Jamestown Canyon Viral Encephalitis"],"prefix":"10.1007","volume":"43","author":[{"given":"Lucie","family":"Roussel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Pham-Huy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea C.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunita","family":"Venkateswaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Bourdel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yichun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanya Tellez","family":"Villavicencio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Bernier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongbiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makayla","family":"Kazimerczak-Brunet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolan","family":"Alattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc-Andr\u00e9","family":"D\u00e9ry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam J.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Penner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1347-7767","authenticated-orcid":false,"given":"Donald C.","family":"Vinh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,11]]},"reference":[{"issue":"5","key":"1580_CR1","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.immuni.2006.09.009","volume":"25","author":"Y Minegishi","year":"2006","unstructured":"Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, Takada H, Hara T, Kawamura N, Ariga T, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity. 2006;25(5):745\u201355.","journal-title":"Immunity"},{"issue":"10","key":"1580_CR2","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1084\/jem.20140280","volume":"212","author":"AY Kreins","year":"2015","unstructured":"Kreins AY, Ciancanelli MJ, Okada S, Kong XF, Ram\u00edrez-Alejo N, Kilic SS, El Baghdadi J, Nonoyama S, Mahdaviani SA, Ailal F, et al. Human TYK2 deficiency: mycobacterial and viral infections without hyper-IgE syndrome. J Exp Med. 2015;212(10):1641\u201362.","journal-title":"J Exp Med"},{"issue":"10","key":"1580_CR3","doi-asserted-by":"publisher","first-page":"e20220094","DOI":"10.1084\/jem.20220094","volume":"219","author":"M Ogishi","year":"2022","unstructured":"Ogishi M, Arias AA, Yang R, Han JE, Zhang P, Rinchai D, Halpern J, Mulwa J, Keating N, Chrabieh M, et al. Impaired IL-23-dependent induction of IFN-\u03b3 underlies mycobacterial disease in patients with inherited TYK2 deficiency. J Exp Med. 2022;219(10):e20220094.","journal-title":"J Exp Med."},{"issue":"1","key":"1580_CR4","doi-asserted-by":"publisher","first-page":"6956","DOI":"10.1038\/s41598-018-25260-8","volume":"8","author":"M Nemoto","year":"2018","unstructured":"Nemoto M, Hattori H, Maeda N, Akita N, Muramatsu H, Moritani S, Kawasaki T, Maejima M, Ode H, Hachiya A, et al. Compound heterozygous TYK2 mutations underlie primary immunodeficiency with T-cell lymphopenia. Sci Rep. 2018;8(1):6956.","journal-title":"Sci Rep"},{"issue":"4","key":"1580_CR5","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1093\/cid\/ciq215","volume":"52","author":"DC Vinh","year":"2011","unstructured":"Vinh DC, Schwartz B, Hsu AP, Miranda DJ, Valdez PA, Fink D, Lau KP, Long-Priel D, Kuhns DB, Uzel G, et al. Interleukin-12 receptor beta1 deficiency predisposing to disseminated Coccidioidomycosis. Clin Infect Dis. 2011;52(4):e99\u2013102.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1580_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/cid\/ciu215","volume":"59","author":"C Gavino","year":"2014","unstructured":"Gavino C, Cotter A, Lichtenstein D, Lejtenyi D, Fortin C, Legault C, Alirezaie N, Majewski J, Sheppard DC, Behr MA, et al. CARD9 deficiency and spontaneous central nervous system candidiasis: complete clinical remission with GM-CSF therapy. Clin Infect Dis. 2014;59(1):81\u20134.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1580_CR7","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.jaci.2015.09.016","volume":"137","author":"C Gavino","year":"2016","unstructured":"Gavino C, Hamel N, Zeng JB, Legault C, Guiot MC, Chankowsky J, Lejtenyi D, Lemire M, Alarie I, Dufresne S, et al. Impaired RASGRF1\/ERK-mediated GM-CSF response characterizes CARD9 deficiency in French-Canadians. J Allergy Clin Immunol. 2016;137(4):1178-1188.e7.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"1580_CR8","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.jaci.2017.02.002","volume":"139","author":"C Gavino","year":"2017","unstructured":"Gavino C, Landekic M, Zeng J, Wu N, Jung S, Zhong MC, Cohen-Blanchet A, Langelier M, Neyret O, Lejtenyi D, et al. Morpholino-based correction of hypomorphic ZAP70 mutation in an adult with combined immunodeficiency. J Allergy Clin Immunol. 2017;139(5):1688-1692 e10.","journal-title":"J Allergy Clin Immunol."},{"issue":"1","key":"1580_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1600-065X.2008.00754.x","volume":"228","author":"K Ghoreschi","year":"2009","unstructured":"Ghoreschi K, Laurence A, O\u2019Shea JJ. Janus kinases in immune cell signaling. Immunol Rev. 2009;228(1):273\u201387.","journal-title":"Immunol Rev"},{"issue":"11","key":"1580_CR10","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.3390\/cancers11111728","volume":"11","author":"K W\u00f6ss","year":"2019","unstructured":"W\u00f6ss K, Simonovi\u0107 N, Strobl B, Macho-Maschler S, M\u00fcller M. TYK2: an upstream kinase of STATs in cancer. Cancers (Basel). 2019;11(11):1728\u201346.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1580_CR11","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/emboj\/cdg038","volume":"22","author":"J Ragimbeau","year":"2003","unstructured":"Ragimbeau J, Dondi E, Alcover A, Eid P, Uz\u00e9 G, Pellegrini S. The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression. Embo j. 2003;22(3):537\u201347.","journal-title":"Embo j"},{"issue":"1","key":"1580_CR12","doi-asserted-by":"publisher","first-page":"e0225289","DOI":"10.1371\/journal.pone.0225289","volume":"15","author":"Z Li","year":"2020","unstructured":"Li Z, Rotival M, Patin E, Michel F, Pellegrini S. Two common disease-associated TYK2 variants impact exon splicing and TYK2 dosage. PLoS ONE. 2020;15(1):e0225289.","journal-title":"PLoS ONE"},{"issue":"16","key":"1580_CR13","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1128\/MCB.05251-11","volume":"31","author":"D Levin","year":"2011","unstructured":"Levin D, Harari D, Schreiber G. Stochastic receptor expression determines cell fate upon interferon treatment. Mol Cell Biol. 2011;31(16):3252\u201366.","journal-title":"Mol Cell Biol"},{"issue":"18","key":"1580_CR14","doi-asserted-by":"publisher","first-page":"7285","DOI":"10.1074\/jbc.R116.774562","volume":"292","author":"G Schreiber","year":"2017","unstructured":"Schreiber G. The molecular basis for differential type I interferon signaling. J Biol Chem. 2017;292(18):7285\u201394.","journal-title":"J Biol Chem"},{"issue":"3","key":"1580_CR15","doi-asserted-by":"publisher","first-page":"F633","DOI":"10.1152\/ajprenal.00015.2008","volume":"295","author":"R Azimov","year":"2008","unstructured":"Azimov R, Abuladze N, Sassani P, Newman D, Kao L, Liu W, Orozco N, Ruchala P, Pushkin A, Kurtz I. G418-mediated ribosomal read-through of a nonsense mutation causing autosomal recessive proximal renal tubular acidosis. Am J Physiol Renal Physiol. 2008;295(3):F633\u201341.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"1580_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13024-020-00369-5","volume":"15","author":"J Frew","year":"2020","unstructured":"Frew J, Baradaran-Heravi A, Balgi AD, Wu X, Yan TD, Arns S, Shidmoossavee FS, Tan J, Jaquith JB, Jansen-West KR, et al. Premature termination codon readthrough upregulates progranulin expression and improves lysosomal function in preclinical models of GRN deficiency. Mol Neurodegener. 2020;15(1):21.","journal-title":"Mol Neurodegener"},{"key":"1580_CR17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev-genom-091212-153527","volume":"15","author":"KM Keeling","year":"2014","unstructured":"Keeling KM, Xue X, Gunn G, Bedwell DM. Therapeutics based on stop codon readthrough. Annu Rev Genomics Hum Genet. 2014;15:371\u201394.","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"2","key":"1580_CR18","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1164\/ajrccm.157.2.9706088","volume":"157","author":"RC Rubenstein","year":"1998","unstructured":"Rubenstein RC, Zeitlin PL. A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: partial restoration of nasal epithelial CFTR function. Am J Respir Crit Care Med. 1998;157(2):484\u201390.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"1580_CR19","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1111\/jth.14236","volume":"16","author":"S Pignani","year":"2018","unstructured":"Pignani S, Todaro A, Ferrarese M, Marchi S, Lombardi S, Balestra D, Pinton P, Bernardi F, Pinotti M, Branchini A. The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation. J Thromb Haemost. 2018;16(10):2035\u201343.","journal-title":"J Thromb Haemost"},{"issue":"3","key":"1580_CR20","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jid.2016.10.035","volume":"137","author":"V Pomozi","year":"2017","unstructured":"Pomozi V, Brampton C, Szeri F, Dedinszki D, Koz\u00e1k E, van de Wetering K, Hopkins H, Martin L, V\u00e1radi A, Le Saux O. Functional rescue of ABCC6 deficiency by 4-phenylbutyrate therapy reduces dystrophic calcification in Abcc6-\/- mice. J Invest Dermatol. 2017;137(3):595\u2013602.","journal-title":"J Invest Dermatol"},{"issue":"8","key":"1580_CR21","doi-asserted-by":"publisher","first-page":"e20220131","DOI":"10.1084\/jem.20220131","volume":"219","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Matuozzo D, Le Pen J, Lee D, Moens L, Asano T, Bohlen J, Liu Z, Moncada-Velez M, Kendir-Demirkol Y, et al. Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia. J Exp Med. 2022;219(8):e20220131.","journal-title":"J Exp Med."},{"issue":"6","key":"1580_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.14745\/ccdr.v41i06a01","volume":"41","author":"MA Drebot","year":"2015","unstructured":"Drebot MA. Emerging mosquito-borne bunyaviruses in Canada. Can Commun Dis Rep. 2015;41(6):117\u201323.","journal-title":"Can Commun Dis Rep"},{"issue":"2","key":"1580_CR23","doi-asserted-by":"publisher","first-page":"384","DOI":"10.4269\/ajtmh.15-0196","volume":"93","author":"DM Pastula","year":"2015","unstructured":"Pastula DM, Hoang Johnson DK, White JL, Dupuis AP 2nd, Fischer M, Staples JE. Jamestown Canyon virus disease in the United States-2000-2013. Am J Trop Med Hyg. 2015;93(2):384\u20139.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"1580_CR24","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4269\/ajtmh.18-0575","volume":"100","author":"E Matkovic","year":"2019","unstructured":"Matkovic E, Hoang Johnson DK, Staples JE, Mora-Pinzon MC, Elbadawi LI, Osborn RA, Warshauer DM, Wegner MV, Davis JP. Enhanced arboviral surveillance to increase detection of Jamestown Canyon virus infections, Wisconsin, 2011\u20132016. Am J Trop Med Hyg. 2019;100(2):445\u201351.","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"1580_CR25","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1002\/eji.201646519","volume":"46","author":"S Fuchs","year":"2016","unstructured":"Fuchs S, Kaiser-Labusch P, Bank J, Ammann S, Kolb-Kokocinski A, Edelbusch C, Omran H, Ehl S. Tyrosine kinase 2 is not limiting human antiviral type III interferon responses. Eur J Immunol. 2016;46(11):2639\u201349.","journal-title":"Eur J Immunol"},{"issue":"5","key":"1580_CR26","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/eji.202048793","volume":"51","author":"I Meyts","year":"2021","unstructured":"Meyts I, Casanova JL. Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway. Eur J Immunol. 2021;51(5):1039\u201361.","journal-title":"Eur J Immunol"},{"issue":"11","key":"1580_CR27","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.tim.2021.03.001","volume":"29","author":"S Stertz","year":"2021","unstructured":"Stertz S, Hale BG. Interferon system deficiencies exacerbating severe pandemic virus infections. Trends Microbiol. 2021;29(11):973\u201382.","journal-title":"Trends Microbiol"},{"issue":"23","key":"1580_CR28","doi-asserted-by":"publisher","first-page":"11638","DOI":"10.1128\/JVI.01570-06","volume":"80","author":"TR Geiger","year":"2006","unstructured":"Geiger TR, Martin JM. The Epstein-Barr virus-encoded LMP-1 oncoprotein negatively affects Tyk2 phosphorylation and interferon signaling in human B cells. J Virol. 2006;80(23):11638\u201350.","journal-title":"J Virol"},{"issue":"80","key":"1580_CR29","doi-asserted-by":"publisher","first-page":"eabq5204","DOI":"10.1126\/sciimmunol.abq5204","volume":"8","author":"Q Philippot","year":"2023","unstructured":"Philippot Q, Ogishi M, Bohlen J, Puchan J, Arias AA, Nguyen T, Martin-Fernandez M, Conil C, Rinchai D, Momenilandi M, et al. Human IL-23 is essential for IFN-\u03b3-dependent immunity to mycobacteria. Sci Immunol. 2023;8(80):eabq5204.","journal-title":"Sci Immunol"},{"issue":"10","key":"1580_CR30","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/humu.22380","volume":"34","author":"E van de Vosse","year":"2013","unstructured":"van de Vosse E, Haverkamp MH, Ramirez-Alejo N, Martinez-Gallo M, Blancas-Galicia L, Metin A, Garty BZ, Sun-Tan \u00c7, Broides A, de Paus RA, et al. IL-12R\u03b21 deficiency: mutation update and description of the IL12RB1 variation database. Hum Mutat. 2013;34(10):1329\u201339.","journal-title":"Hum Mutat"},{"issue":"2","key":"1580_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/MD.0b013e31828a01f9","volume":"92","author":"C Prando","year":"2013","unstructured":"Prando C, Samarina A, Bustamante J, Boisson-Dupuis S, Cobat A, Picard C, AlSum Z, Al-Jumaah S, Al-Hajjar S, Frayha H, et al. Inherited IL-12p40 deficiency: genetic, immunologic, and clinical features of 49 patients from 30 kindreds. Medicine (Baltimore). 2013;92(2):109\u201322.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"1580_CR32","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","volume":"26","author":"J Bustamante","year":"2014","unstructured":"Bustamante J, Boisson-Dupuis S, Abel L, Casanova JL. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-\u03b3 immunity. Semin Immunol. 2014;26(6):454\u201370.","journal-title":"Semin Immunol"},{"issue":"10","key":"1580_CR33","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/S1473-3099(11)70217-1","volume":"11","author":"DC Vinh","year":"2011","unstructured":"Vinh DC. Insights into human antifungal immunity from primary immunodeficiencies. Lancet Infect Dis. 2011;11(10):780\u201392.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"1580_CR34","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1080\/1744666X.2019.1584038","volume":"15","author":"DC Vinh","year":"2019","unstructured":"Vinh DC. The molecular immunology of human susceptibility to fungal diseases: lessons from single gene defects of immunity. Expert Rev Clin Immunol. 2019;15(5):461\u201386.","journal-title":"Expert Rev Clin Immunol"},{"issue":"7","key":"1580_CR35","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.1074\/jbc.273.7.4046","volume":"273","author":"H Yan","year":"1998","unstructured":"Yan H, Piazza F, Krishnan K, Pine R, Krolewski JJ. Definition of the interferon-alpha receptor-binding domain on the TYK2 kinase. J Biol Chem. 1998;273(7):4046\u201351.","journal-title":"J Biol Chem"},{"issue":"38","key":"1580_CR36","doi-asserted-by":"publisher","first-page":"24723","DOI":"10.1074\/jbc.273.38.24723","volume":"273","author":"MF Richter","year":"1998","unstructured":"Richter MF, Dum\u00e9nil G, Uz\u00e9 G, Fellous M, Pellegrini S. Specific contribution of Tyk2 JH regions to the binding and the expression of the interferon alpha\/beta receptor component IFNAR1. J Biol Chem. 1998;273(38):24723\u20139.","journal-title":"J Biol Chem"},{"issue":"19","key":"1580_CR37","doi-asserted-by":"publisher","first-page":"5894","DOI":"10.1093\/emboj\/16.19.5894","volume":"16","author":"SV Kotenko","year":"1997","unstructured":"Kotenko SV, Krause CD, Izotova LS, Pollack BP, Wu W, Pestka S. Identification and functional characterization of a second chain of the interleukin-10 receptor complex. Embo j. 1997;16(19):5894\u2013903.","journal-title":"Embo j"},{"key":"1580_CR38","first-page":"191","volume":"380","author":"MR Walter","year":"2014","unstructured":"Walter MR. The molecular basis of IL-10 function: from receptor structure to the onset of signaling. Curr Top Microbiol Immunol. 2014;380:191\u2013212.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"1580_CR39","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.cyto.2014.11.018","volume":"71","author":"RT Robinson","year":"2015","unstructured":"Robinson RT. IL12R\u03b21: the cytokine receptor that we used to know. Cytokine. 2015;71(2):348\u201359.","journal-title":"Cytokine"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-023-01580-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-023-01580-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-023-01580-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T05:32:35Z","timestamp":1700458355000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-023-01580-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,11]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["1580"],"URL":"https:\/\/doi.org\/10.1007\/s10875-023-01580-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2817321\/v1","asserted-by":"object"}]},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,11]]},"assertion":[{"value":"17 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Research Ethics Board of the Research Institute \u2013 McGill University Health Centre has approved this research (No. 2021\u20136624).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors confirm that a relevant local consent has been signed by the patient and\/or the legally authorized representative.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors confirm that a relevant local consent has been signed by the patient and\/or the legally authorized representative.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"D.C. Vinh has received research support, unrestricted educational grants, consultancy fees, and speaker honoraria from CSL Behring; has received consultancy fees from AstraZeneca, Moderna, and Takeda; and has undertaken clinical trials for Cidara Therapeutics and Moderna. The remaining authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}